Alterity Therapeutics
ATHE
13 hedge funds and large institutions have $654K invested in Alterity Therapeutics in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
32% more capital invested
Capital invested by funds: $494K → $654K (+$160K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
7% less funds holding
Funds holding: 14 → 13 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$96.9K |
| 2 |
VF
Virtu Financial
New York
|
+$66.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.82K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$39K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$13K |
| 3 |
NFG
Next Financial Group
Houston,
Texas
|
-$2K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$1.57K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$784 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $552K | +$96.9K | +3,090 | +21% |
|
|
VF
2
Virtu Financial
New York
| $66K | +$66.3K | +2,113 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $15K | +$2.82K | +90 | +23% |
|
|
AG
4
Advisor Group
Phoenix,
Arizona
| $8K | – | – | – |
|
|
5
Bank of America
Charlotte,
North Carolina
| $3K | -$784 | -25 | -21% |
|
|
AIM
6
Advantage Investment Management
Cedar Rapids,
Iowa
| $3K | – | – | – |
|
7
Wells Fargo
San Francisco,
California
| $3K | – | – | – |
|
|
LC
8
Landaas & Company
Milwaukee,
Wisconsin
| $2K | – | – | – |
|
9
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $2K | – | – | – |
|
|
APA
10
American Portfolios Advisors
Holbrook,
New York
| $259 | +$251 | +8 | New |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$39K | -1,400 | Closed |
|
|
12
Acadian Asset Management
Boston,
Massachusetts
| – | -$13K | -464 | Closed |
|
|
NFG
13
Next Financial Group
Houston,
Texas
| – | -$2K | -58 | Closed |
|
|
14
Group One Trading
Chicago,
Illinois
| – | -$1.57K | -50 | -93% |
|
ATHE Hedge Fund Activity: Q4 2017 in Review
13 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q4 2017, worth a combined $654K — up 32% from $494K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ATHE and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was Morgan Stanley, adding an estimated $96.9K. The largest seller was Citadel Advisors, exiting entirely with an estimated $39K sold.
- 13 institutional investors held Alterity Therapeutics (ATHE) as of Q4 2017, down from 14 in Q3 2017.
- Funds reported $654K of Alterity Therapeutics stock for Q4 2017, up 32% quarter-over-quarter.
- 2 funds opened new Alterity Therapeutics positions in Q4 2017 and 3 closed out, a net change of -1 holder.
- The largest Alterity Therapeutics buyer in Q4 2017 was Morgan Stanley, an estimated $96.9K added.
- The largest Alterity Therapeutics seller in Q4 2017 was Citadel Advisors, an estimated $39K sold.
Based on aggregated 13F filings for Q4 2017.